Jane Street’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
+93,980
| New | +$322K | ﹤0.01% | 4231 |
|
|
2025
Q1 | – | Sell |
-128,407
| Closed | -$376K | – | 5504 |
|
|
2024
Q4 | $376K | Buy |
128,407
+22,455
| +21% | +$65.8K | ﹤0.01% | 4346 |
|
|
2024
Q3 | $275K | Sell |
105,952
-48,820
| -32% | -$127K | ﹤0.01% | 4945 |
|
|
2024
Q2 | $458K | Buy |
154,772
+55,887
| +57% | +$165K | ﹤0.01% | 4614 |
|
|
2024
Q1 | $448K | Sell |
98,885
-144,555
| -59% | -$655K | ﹤0.01% | 4184 |
|
|
2023
Q4 | $1.39M | Buy |
243,440
+131,348
| +117% | +$750K | ﹤0.01% | 2921 |
|
|
2023
Q3 | $516K | Sell |
112,092
-25,154
| -18% | -$116K | ﹤0.01% | 3579 |
|
|
2023
Q2 | $887K | Buy |
137,246
+88,124
| +179% | +$569K | ﹤0.01% | 3181 |
|
|
2023
Q1 | $370K | Buy |
49,122
+29,251
| +147% | +$221K | ﹤0.01% | 4004 |
|
|
2022
Q4 | $201K | Sell |
19,871
-5,230
| -21% | -$53K | ﹤0.01% | 4389 |
|
|
2022
Q3 | $248K | Sell |
25,101
-16,401
| -40% | -$162K | ﹤0.01% | 4367 |
|
|
2022
Q2 | $442K | Buy |
+41,502
| New | +$442K | ﹤0.01% | 3689 |
|
|
2022
Q1 | – | Sell |
-384,146
| Closed | -$5.49M | – | 5567 |
|
|
2021
Q4 | $5.49M | Buy |
384,146
+303,389
| +376% | +$4.34M | ﹤0.01% | 1010 |
|
|
2021
Q3 | $1.62M | Sell |
80,757
-33,964
| -30% | -$680K | ﹤0.01% | 2090 |
|
|
2021
Q2 | $2.52M | Buy |
114,721
+74,954
| +188% | +$1.65M | ﹤0.01% | 1526 |
|
|
2021
Q1 | $1.35M | Buy |
39,767
+24,844
| +166% | +$843K | ﹤0.01% | 2120 |
|
|
2020
Q4 | $601K | Buy |
+14,923
| New | +$601K | ﹤0.01% | 2581 |
|